tiprankstipranks
Allergy Therapeutics PLC (AGYTF)
OTHER OTC:AGYTF

Allergy Therapeutics (AGYTF) Balance Sheet

2 Followers

Allergy Therapeutics Balance Sheet

Allergy Therapeutics's total assets for Q4 2022 were £73.58M, a decrease of -20.00% from the previous quarter. AGYTF total liabilities were £35.18M for the fiscal quarter, a -4.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Jun 23Jun 22Jun 21Jun 20Jun 19
Total Assets
£ 66.77M£ 73.58M£ 88.09M£ 86.22M£ 68.50M
Total Liabilities
£ 64.70M£ 35.18M£ 39.55M£ 42.44M£ 30.94M
Total Equity Gross Minority
£ 2.07M£ 38.40M£ 48.53M£ 43.78M£ 37.56M
Total Capitalization
£ 28.50M£ 39.89M£ 50.98M£ 46.71M£ 39.30M
Preferred Stock Equity
-----
Capital Lease Obligations
---£ 8.42M£ 0.00
Currency in GBP

Allergy Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis